Refine by
Haematological Malignancies Services
4 services found
by:Lucence Health Inc. based inPalo Alto, CALIFORNIA (USA)
HemeMARK™ is a next-generation sequencing assay that analyzes 45 cancer-related gene mutations in hematological malignancies including myeloid and lymphoid ...
Manufactured by:Foundation Medicine, Inc. based inCambridge, MASSACHUSETTS (USA)
Discover tissue AND blood-based FDA-approved comprehensive genomic profiling testing for all solid tumors with FoundationOne®CDx and FoundationOne®Liquid CDx. In addition, FoundationOne®Heme is a laboratory developed test for hematologic malignancies, sarcomas, or solid tumors where fusion detection is desired. ...
by:Vor Biopharma based inCambridge, MASSACHUSETTS (USA)
The traditional tumor target paradigm aims to treat hematological malignancies such as acute myeloid leukemia (AML) by focusing on the specificity and potency of therapies that kill cancer cells expressing a target. However, this paradigm is limited by the expression of tumor targets on healthy cells, resulting in on-target toxicity. On-target toxicity has led to the development failure of many ...
by:NeoGenomics Laboratories based inFort Myers, FLORIDA (USA)
Cytogenetics is the study of normal and abnormal chromosomes in relation to disease. Sometimes called chromosome analysis or karyotyping, cytogenetic tests are used to gain diagnostic and prognostic insights regarding solid tumor cancers and hematologic malignancies, which can be the result of chromosome rearrangements or altered chromosome number (ploidy). Our cytogenetic tests include a ...